Product Information
ARIMIDEX 1 MG TABLET is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $52.8616 per EA under NDC 62559067030. Its NADAC has been published 196 times since Nov 7, 2018.
FDA first approved this application on Dec 27, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Anastrozole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559067030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANASTROZOLEApproval Type
New Drug (NDA)
FDA Application
NDA020541FDA Approved
12/27/1995
TE Code
AB
On Market Since
6/26/2018
Pharmacological Classes
Price Statistics
The NADAC for ARIMIDEX 1 MG TABLET has been published 196 times since Nov 7, 2018, and over the history we have for it it has risen 214.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $52.8616 per EA |
|---|---|
| All-time high | $52.8616 (Sep 30, 2026) |
| All-time low | $16.7911 (Nov 7, 2018) |
| 52-week high | $52.8616 |
| 52-week low | $51.9824 |
| Median price | $51.9423 |
| Average price | $48.7661 |
| Largest weekly change | +136.2% (Nov 21, 2018) |
| Weeks tracked | 196 |
| Tracking since | Nov 7, 2018 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Anastrozole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aromatase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIMIDEX 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIMIDEX 1 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $52.8616 per EA (NDC 62559067030), effective Sep 30, 2026.
How has the price of ARIMIDEX 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIMIDEX 1 MG TABLET has risen 214.8%. It has been tracked across 196 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for ARIMIDEX 1 MG TABLET?
Since Nov 7, 2018, the NADAC for ARIMIDEX 1 MG TABLET has ranged from a low of $16.7911 (Nov 7, 2018) to a high of $52.8616 (Sep 30, 2026), with a median of $51.9423 per EA.
Are there cheaper alternatives to ARIMIDEX 1 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANASTROZOLE 1 MG TABLET, is $0.1366 per EA — about 99% below ARIMIDEX 1 MG TABLET.
Who manufactures ARIMIDEX 1 MG TABLET?
ARIMIDEX 1 MG TABLET (NDC 62559067030) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.